References
- 1. Chujo K, Shima K, Tada H,Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J Med Invest. 2006; 53:223-8.10.2152/jmi.53.223
- 2. Inaba M, Okuno S, Kumeda Y, Yamada S, Inamishi Y, Tabata. T, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephro. 2007; 18:895-903.10.1681/ASN.2006070772
- 3. Peacock TP, Shihabi ZK, Bleyer, AJ Dolbare EL, Byers JR, Krovich MA, et al. Comparison of glycated albumin and hemoglobin A1c levels in diabetic patients on hemodialysis. Kidney Int. 2008; 73:1062-8.
- 4. Freedman BI, Shenoy RN, Planer JA,Clay KD, Shihabi ZK, Burkart JM, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010; 30:72-9.
- 5. Viswanathan V, Kumpatla S, Tilak P, Muthukumaran P. Levels of glycated albumin at different stages of diabetic nephropathy in India. Int J Diabetes Metab. 2009; 17:77-80.
- 6. Uzu T, Hatta T, Deji N, Izumiya T, Ueda H, Miyazawa I, et al. Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A1c. Ther Apheresis and Dialysis. 2009; 13:89-94
- 7. Mehrotra R, Kalantar-Zadeh K, Adler S. Assessment of glycemic control in dialysis patients with diabetes: glycosylated hemoglobin or glycated albumin? Clin J Am Soc Nephrol. 2011; 6:1520-2.10.2215/CJN.04210511
- 8. Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, Okazaki S, Nishizawa Y, et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother. 2009; 63:236-40.
- 9. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-86.
- 10. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352(9131):837-53.
- 11. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2011, 47:453-63
- 12. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med. 1998; 37: 826-30.10.2169/internalmedicine.37.826
- 13. Johnson RN, Baker JR. Error detection and measurement in glucose monitors. Clin Chim Acta. 2001; 307:1-67
- 14. Riveline JP, Teynie J, Belmouaz S, Franc S, Dardari D, Bauwens M, et al. Glycaemic control of type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol Dial Transplant. 2009, 24:2866-71
- 15. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology. 2012; 17:82-188.10.1111/j.1440-1797.2011.01517.x
- 16. Tahara Y, Shima K. The response of GHb to step-wise plasma glucose change over time in diabetic patients. Diabetes Care. 1993; 16:1313-410.2337/diacare.16.9.1313
- 17. Yoshiuchi K, Matsuhisa M, Katakami N Nakatani Y, Sakamoto K, Matsuoka T, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J. 2008; 55:503-7.10.1507/endocrj.K07E-089
- 18. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010; 57:135-40.10.1507/endocrj.K09E-234
- 19. Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, Someya Y, et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta. 2007; 382: 59-64.